Navigation Links
VIB exceptionally sceptical about the Sralini research
Date:9/20/2012

The VIB scientists had serious reservations about the Sralini publication, which appeared today in the journal Food and Chemical Toxicology. The conclusions drawn by Sralini could not be derived from the publication. The data will have to be subjected to a thorough analysis.

VIB points out that Sralini is a controversial researcher. "Sralini has published similar accounts before, but not one of them has withstood scientific scrutiny. That is because he draws conclusions that cannot be derived from the data. The European Food Safety Authority (EFSA) has examined Sralini's previous study about GM maize for the European Commission. His conclusions were not followed on the basis of sound scientific elements and the EFSA repeated its recommendations concerning GM maize."

VIB emphasized the many studies that have demonstrated the safety of GM maize. "In the United States transgenic maize has been grown for seventeen years for human consumption and as cattle feed. These crops were naturally subjected to the toxicity tests required for commercial use and were found to be safe. In view of the polarization surrounding GM crops in Europe, a massive number of studies have already been carried out into possible toxic effects of GM crops. These have shown that GM crops are as safe for human and animal consumption as non-GM crops.

VIB is a proponent of studies concerning the safety of GM crops but insists that these have to be carried out in a thorough and scientifically responsible way. VIB regrets that incorrectly performed studies damage the reputation of GM organisms and plant biotechnology in general.


'/>"/>

Contact: Kris Van der Beken
kris.vanderbeken@vib.be
32-473-783-435
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1

Related biology news :

1. VIB exceptionally sceptical about the Séralini research
2. Teaching about hearing can save young peoples ears
3. A birds song may teach us about human speech disorders
4. Fielding questions about climate change
5. New research about facial recognition turns common wisdom on its head
6. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
7. Expedition to undersea mountain yields new information about sub-seafloor structure
8. Consumers need simple, concise messages about benefits of phytonutrients
9. Whats in a surname? New study explores what the evolution of names reveals about China
10. Analysis raises atmospheric, ecologic and economic doubts about forest bioenergy
11. Fruit flies provide new knowledge about uninhibited cell growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology: